scispace - formally typeset
L

Lothar Rink

Researcher at RWTH Aachen University

Publications -  254
Citations -  15719

Lothar Rink is an academic researcher from RWTH Aachen University. The author has contributed to research in topics: Zinc & Immune system. The author has an hindex of 63, co-authored 235 publications receiving 13189 citations. Previous affiliations of Lothar Rink include University of Lübeck & Laval University.

Papers
More filters
Journal ArticleDOI

Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.

TL;DR: Cumulatively, zinc supplementation seems to be capable to induce tolerance in unwanted immune reactions by increasing iTreg cells, which makes zinc a promising future tool for treating autoimmune diseases without suppressing the immune system.
Journal ArticleDOI

Chelation of Free Zn2+ Impairs Chemotaxis, Phagocytosis, Oxidative Burst, Degranulation, and Cytokine Production by Neutrophil Granulocytes

TL;DR: Free intracellular Zn2+ plays essential roles in multiple neutrophil functions, affecting extravasation to the site of the infection, uptake and killing of microorganisms, and inflammation.
Journal ArticleDOI

Zinc in pharmacological doses suppresses allogeneic reaction without affecting the antigenic response.

TL;DR: In in vitro experiments, it is shown that zinc maintains the antigenic potency of the host while blocking the allogeneic response, which is the first step towards a new generation of immunosuppressants.
Journal ArticleDOI

Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects.

TL;DR: Zinc may regulate unwanted hyperresponsive immune reactions by suppressing proliferation through a significant shift from IL-10 to the Th1 cytokine IFN-γ, and enhanced regulatory T cell numbers, without negatively affecting the immune system.
Journal Article

Zinc enhances lipopolysaccharide-induced monokine secretion by alteration of fluidity state of lipopolysaccharide.

TL;DR: The data indicate that the zinc level represents a relevant clinical parameter in the treatment of Gram-negative infection, and reveals potential risks in the therapeutic application of zinc.